Faruk Recep Özalp

4PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 27, 2026
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|May 25, 2026
Integrative in silico transcriptomic and pharmacogenomic analysis of CD276 as a candidate prognostic biomarker and therapeutic target in bladder cancer.

|Sep 27, 2025
Evaluation of the Meet-URO Score in a Real-World Cohort of mRCC Patients Treated with First-Line TKIs.

Faruk Recep Özalp, Ece Şahin Hafızoğlu, Ahmet Melih Arslan

|Nov 29, 2024
Prognostic value of B7-H3 expression in metastatic renal cell carcinoma and its impact on immunotherapy response.

Faruk Recep Özalp, Kutsal Yörükoğlu, Eda Çalışkan Yıldırım

Pageof 1

Frequent Collaborators

2 joint publications

Sedat Biter

2 joint publications

Hüseyin Salih Semiz

1 joint publications

Ece Şahin Hafızoğlu

1 joint publications

Ahmet Melih Arslan